Biology Reference
In-Depth Information
196. Logozzi M et al (2009) High levels of exosomes expressing CD63 and caveolin-1 in plasma
of melanoma patients. PLoS One 4(4):e5219
197. Rabinowits G et al (2009) Exosomal microRNA: a diagnostic marker for lung cancer. Clin
Lung Cancer 10(1):42-46
198. Smalley DM et al (2008) Isolation and identification of potential urinary microparticle bio-
markers of bladder cancer. J Proteome Res 7(5):2088-2096
199. Rupp AK et al (2011) Loss of EpCAM expression in breast cancer derived serum exosomes:
role of proteolytic cleavage. Gynecol Oncol 122(2):437-446
200. Shigehara K et al (2011) Real-time PCR-based analysis of the human bile microRNAome
identifies miR-9 as a potential diagnostic biomarker for biliary tract cancer. PLoS One
6(8):e23584
201. Hanke M et al (2010) A robust methodology to study urine microRNA as tumor marker:
microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol Oncol
28(6):655-661
202. Yamada Y et al (2011) MiR-96 and miR-183 detection in urine serve as potential tumor mark-
ers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary
cytology. Cancer Sci 102(3):522-529
203. Heneghan HM et al (2010) Circulating microRNAs as novel minimally invasive biomarkers
for breast cancer. Ann Surg 251(3):499-505
204. Wang F et al (2010) Correlation and quantitation of microRNA aberrant expression in tissues
and sera from patients with breast tumor. Gynecol Oncol 119(3):586-593
205. Huang Z et al (2010) Plasma microRNAs are promising novel biomarkers for early detection
of colorectal cancer. Int J Cancer 127(1):118-126
206. Tsujiura M et al (2010) Circulating microRNAs in plasma of patients with gastric cancers. Br
J Cancer 102(7):1174-1179
207. Liu R et al (2011) A five-microRNA signature identified from genome-wide serum microRNA
expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer
47(5):784-791
208. Shigoka M et al (2010) Deregulation of miR-92a expression is implicated in hepatocellular
carcinoma development. Pathol Int 60(5):351-357
209. Yamamoto Y et al (2009) MicroRNA-500 as a potential diagnostic marker for hepatocellular
carcinoma. Biomarkers 14(7):529-538
210. Li LM et al (2010) Serum microRNA profiles serve as novel biomarkers for HBV infection
and diagnosis of HBV-positive hepatocarcinoma. Cancer Res 70(23):9798-9807
211. Tanaka M et al (2009) Down-regulation of miR-92 in human plasma is a novel marker for
acute leukemia patients. PLoS One 4(5):e5532
212. Moussay E et al (2010) Determination of genes and microRNAs involved in the resistance to
fludarabine in vivo in chronic lymphocytic leukemia. Mol Cancer 9:115
213. Leidinger P et al (2010) High-throughput miRNA profiling of human melanoma blood sam-
ples. BMC Cancer 10:262
214. Unno K et al (2009) Identification of a novel microRNA cluster miR-193b-365 in multiple
myeloma. Leuk Lymphoma 50(11):1865-1871
215. Hu Z et al (2010) Serum microRNA signatures identified in a genome-wide serum microRNA
expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol
28(10):1721-1726
216. Wong TS et al (2008) Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell
Carcinoma of Tongue. Clin Cancer Res 14(9):2588-2592
217. Liu CJ et al (2010) Increase of microRNA miR-31 level in plasma could be a potential marker
of oral cancer. Oral Dis 16(4):360-364
Search WWH ::
Custom Search